Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 3,528,745
- Total 13F value
- $3,034,778
- Share change
- +149,200
- Put/Call ratio
- 6.1%
- SEC-reported price per share
- $0.86
- Number of holders
- 38
- Value change
- +$127,744
- Number of buys
- 8
- Number of sells
- 9
- Shares outstanding
- 11,627,985
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
38
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Clearline Capital LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
13D/G
3/4/5
Lead comparable stake: 5.5%
13D/G row: Clearline Capital LP
Showing 1-6 of 15 holder rows.
Quick read
Clearline Capital LP leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Clearline Capital LP's linked filing trail.
Comparable ownership
Top 5
Clearline Capital LP
5.5%
Rubric Capital Management LP
10%
Tejara Capital Ltd
3.5%
VANGUARD GROUP INC
3.3%
ADAR1 Capital Management, LLC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Clearline Capital LP |
13F
13D/G
Company
|
5.5%
from 13D/G
|
$1,056,793
636,622 shares
|
— | 30 Sep 2024 |
| Rubric Capital Management LP |
3/4/5
13F
Director, Other*, 10%+ Owner · Company
|
10%
from 13F
|
$6,718,950
2,946,908 shares
|
— | 15 Nov 2023 |
| Tejara Capital Ltd |
13F
Company
|
3.5%
|
$666,400
401,446 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$643,386
387,582 shares
|
— | 30 Sep 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
2.3%
|
$448,466
270,160 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
1.1%
|
$218,654
131,719 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
3,528,745
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
34
Q4 2024 holders
38
Holder diff
4
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|